Development and Validation of a Prognostic Gene Signature in Clear Cell Renal Cell Carcinoma

Development and Validation of a Prognostic Gene Signature in Clear Cell Renal Cell Carcinoma

Clear cell renal cell carcinoma (ccRCC), one of the most common urologic cancer types, has a relatively good prognosis. However, clinical diagnoses are mostly done during the medium or late stages, when mortality and recurrence rates are quite high. Therefore, it is important to perform real-time in...

Full description

Bibliographic Details
Main Authors: Chuanchuan Zhan, Zichu Wang, Chao Xu, Xiao Huang, Junzhou Su, Bisheng Chen, Mingshan Wang, Zhihong Qi, Peiming Bai
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-04-01
Series:Frontiers in Molecular Biosciences
Subjects:
kidney cancer
microarray
WGCNA
targeting therapy
novel markers
prognostic model
Online Access:https://www.frontiersin.org/articles/10.3389/fmolb.2021.609865/full

Internet

https://www.frontiersin.org/articles/10.3389/fmolb.2021.609865/full

Similar Items